Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2003
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis
11/12/2003EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359934A2 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
11/12/2003EP1359933A2 Treatment of demyelinating diseases by administering gpe
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359919A1 Method of treating substance abuse with quetiapine
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359914A2 Novel therapeutic use of a thienylcyclohexylamine derivative
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1140128B1 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans
11/12/2003EP1117417B1 Pharmaceutically active plant preparation for the treatment of migraine
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP1007524B1 Indole derivatives as 5-ht1b and 5-ht1d agonists
11/12/2003EP0996618B1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
11/12/2003EP0991618B1 Selective thyroid hormone analogs
11/12/2003EP0979087B1 Analgesic combination
11/12/2003EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
11/12/2003EP0970379B1 Methods to identify beta-amyloid reducing agents
11/12/2003EP0517850B1 Compositions and methods of treatment of sympathetically maintained pain
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455770A (2-azabicyclo [2,2,1] hept-7-yl] methanol derivatives as nicotinic acetylcholine receptor agonisis
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455670A Combination of lipoic acids and conjugated acids for treating diabetic disorders
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1454643A Chinese medicine for treatment of drug-addiction and preparing process thereof
11/12/2003CN1454632A Full gastrodia soft capsule and preparing method thereof
11/12/2003CN1454608A Medicine for preventing and curing cerebrovascular dementia
11/12/2003CN1454603A Chinese medicine composition for curing hepatitis B and hepatitis B concurrent mental idness
11/12/2003CN1454600A Hiliezdum fast-release tablet and preparing method thereof
11/12/2003CN1454599A Rhodiola total tanning matter extract and use for preparing medicine for curing senile dementia
11/12/2003CN1454597A Oral slow-release and controlled-release preparation for curing depression
11/12/2003CN1454526A Functional health-care beverage for helping to sobering one
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127502C Salts of paroxetine
11/12/2003CN1127499C Novel form of irbesartan, Methods of obtaining said form and pharmaceutical compositions containing same
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/12/2003CN1127480C Colchicine derivative and its treatment use
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645985 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them, and method of treating
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645975 Process for the preparation of dinaposoline
11/11/2003US6645973 Heterocyclic amines such as 1-carboxymethyl-4-(4-chlorophenyl) spiro(2H-1-benzopyran-2,4'-piperidine)hydrochloride used for therapy of nervous system disorders; Alzheimer's, Parkinson's and Huntington's disease
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645527 Stabilized sustained release tramadol formulations
11/11/2003US6645523 Paroxetine compositions and processes for making the same
11/11/2003US6645521 Local prevention or amelioration of pain from surgically closed wounds
11/11/2003US6645496 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion by administering Botulinum toxin type A
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2143756C N-cyano-n'-pyridylguanidines as serotonin antagonists
11/11/2003CA2113424C Muscarinic agonists
11/11/2003CA2091440C 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
11/06/2003WO2003091675A2 Ultrasonic doppler effect speed measurement
11/06/2003WO2003091449A1 Method of measuring neprilysin activity
1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 1833